Catalent Stock Price To Sales
Catalent fundamentals help investors to digest information that contributes to Catalent's financial success or failures. It also enables traders to predict the movement of Catalent Stock. The fundamental analysis module provides a way to measure Catalent's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Catalent stock.
Catalent |
Catalent Company Price To Sales Analysis
Catalent's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Catalent Price To Sales | 2.61 X |
Most of Catalent's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Catalent is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Catalent has a Price To Sales of 2.6057 times. This is 87.82% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 77.18% higher than that of the company.
Catalent Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Catalent's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Catalent could also be used in its relative valuation, which is a method of valuing Catalent by comparing valuation metrics of similar companies.Catalent is currently under evaluation in price to sales category among its peers.
Catalent Fundamentals
| Return On Equity | -0.11 | |||
| Return On Asset | -0.0018 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (0.07) % | |||
| Current Valuation | 16.13 B | |||
| Shares Outstanding | 181.51 M | |||
| Shares Owned By Insiders | 0.50 % | |||
| Shares Owned By Institutions | 87.80 % | |||
| Number Of Shares Shorted | 14.74 M | |||
| Price To Earning | 17.80 X | |||
| Price To Book | 3.25 X | |||
| Price To Sales | 2.61 X | |||
| Revenue | 4.38 B | |||
| Gross Profit | 1.04 B | |||
| EBITDA | (284 M) | |||
| Net Income | (1.04 B) | |||
| Cash And Equivalents | 345 M | |||
| Cash Per Share | 1.92 X | |||
| Total Debt | 4.92 B | |||
| Debt To Equity | 0.90 % | |||
| Current Ratio | 2.86 X | |||
| Book Value Per Share | 19.52 X | |||
| Cash Flow From Operations | 268 M | |||
| Short Ratio | 7.89 X | |||
| Earnings Per Share | (2.28) X | |||
| Price To Earnings To Growth | 529.00 X | |||
| Target Price | 63.4 | |||
| Number Of Employees | 17 K | |||
| Beta | 1.16 | |||
| Market Capitalization | 11.52 B | |||
| Total Asset | 9.75 B | |||
| Retained Earnings | (781 M) | |||
| Working Capital | 1.57 B | |||
| Current Asset | 790.2 M | |||
| Current Liabilities | 391.2 M | |||
| Net Asset | 9.75 B |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Catalent Stock
If you are still planning to invest in Catalent check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalent's history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |